AxImmune
Manufacturing · Colorado, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
320 E Vine Dr Ste 120, Fort Collins, Col...Phone Number
(540) 239-0668Website
www.aximmune.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About AxImmune
AxImmune Inc. is focused on developing clinical stage immuno-oncology technology, specifically the Ax-101 drug, which has shown potent anti-tumor activity and works synergistically with immune checkpoint inhibitors. The company aims to improve cancer treatment outcomes and expand the range of cancers that can be treated with existing ICI drugs. AxImmune plans to initiate clinical trials following the completion of preclinical testing, with a strong advisory board of key opinion leaders in the field. Their intended clients include patients with various cancers who have functioning immune systems and may benefit from enhanced treatment options.Explore more
Popular SearchesAximmune IncAximmuneSIC Code 28,283NAICS Code 32,325Show more
AxImmune Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AxImmune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on AxImmune recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at AxImmune
Click to see if AxImmune had a recent Job posting/layoffs
Check out if AxImmune is spiking on competitors!
Product Launch: Get notified when AxImmune launches new products
Website visits: Recent activity has been detected on your website
AxImmune, which may be a good buyer, showed buying intent in Masked Content Topic
Check if AxImmune has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once AxImmune has new funding data
Recommended Actions
Find VP level buyers at AxImmune
Find more new buyers
Compare Similar Companies to AxImmune
Compare insights from companies similar to AxImmune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AxImmune is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AxImmune is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AxImmune.
AxImmune financials insights
Gather financial insights about AxImmune, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$88K
AxImmune Tech Stack
A closer look at the technologies used by AxImmune
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AxImmune
Sign Up For FreeTo access detailed company insights
AxImmune Inc. is focused on developing clinical stage immuno-oncology technology, specifically the Ax-101 drug, which has shown potent anti-tumor activity and works synergistically with immune checkpoint inhibitors. The company aims to improve cancer treatment outcomes and expand the range of cancers that can be treated with existing ICI drugs. AxI... Read More
